FormDSignal
40

Conexeu Sciences raises $3M in Nevada biotech offering under Reg D 506(b)

Company raise · Raising · RENO, NV · Form D filed 2026-10-21

Conexeu Sciences Inc., a Nevada biotech corporation incorporated in 2022, is raising $3M under Regulation D exemption 506(b). The company has sold $1.5M to 2 investors so far and seeks an additional $1.5M.

operating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

DAVID R BOGARTExecutive Officer, Director
MILES HARRISONExecutive Officer, Director
AARON FARBERGDirector
STEPHEN D INOUYEExecutive Officer
CLAUDIA CHAVEZ-MUNOZExecutive Officer
JEFF SHARPEDirector
Z PAUL LORENCDirector
SEBASTIAN PURCELLDirector
BRIAN PILCHERExecutive Officer
ANDREW COSTADirector
APRIL BURKEDirector
ANA BASTIANI-POSNERDirector

Signed by Stephen Inouye, CFO.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer